Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.
BACKGROUND: Stratified medicine aims to improve clinical and cost-effectiveness by identifying moderators of treatment that indicate differential response to treatment. Cognitive behavioural therapy (CBT) is often offered as a 'next-step' for patients who have not responded to antidepressa...
Main Authors: | Button, K, Turner, N, Campbell, J, Kessler, D, Kuyken, W, Lewis, G, Peters, T, Thomas, L, Wiles, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2014
|
Similar Items
-
Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial protocol.
by: Thomas, L, et al.
Published: (2012) -
Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial.
by: Hollinghurst, S, et al.
Published: (2014) -
Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial.
by: Wiles, N, et al.
Published: (2013) -
Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
by: Wiles, N, et al.
Published: (2014) -
Cognitive behavioural therapy for treatment-resistant depression - Authors' reply.
by: Wiles, N, et al.
Published: (2013)